Onego Bio

📍 Helsinki, Finland👥 44 employees💰 Last funded Mar 2024
Food and Beverage Manufacturing🌐 onego.bio
Website LinkedIn
Onego Bio is a US-Finnish food-biotech company revolutionizing the food system by harnessing the power of precision fermentation to manufacture real egg protein entirely animal-free. Their ingredient, Bioalbumen®, sets a new standard for sustainable protein with identical taste and nutrition, superior functional properties and over 90% smaller environmental footprint compared to eggs from chickens. Onego’s highly efficient and scalable technology caters to the needs of the food industry searching for stable, sustainable functional ingredients. As a game-changer in the field, the company was selected the Winner of Fast Company’s 2023 World Changing Ideas awards and is a co-founder of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
2
Frequently asked questions
Who invested in Onego Bio?
Onego Bio has 2 investors on record on gritt.io.
When did Onego Bio last raise funding?
The most recent investment in Onego Bio recorded on gritt.io was in March 2024.
What industry is Onego Bio in?
Onego Bio operates in Food and Beverage Manufacturing. Find similar Food and Beverage Manufacturing investors on gritt.io.
Where is Onego Bio based?
Onego Bio is headquartered in Helsinki, Finland.